We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

1 hedge funds and large institutions have $649 invested in BELLUS Health Inc. in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% less funds holding

Funds holding: 111 (-10)

91% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 11

100% less capital invested

Capital invested by funds: $6.71M → $649 (-$6.71M)

Holders
1
Holders Change
-10
Holders Change %
-90.91%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CAS
1
Coppell Advisory Solutions
Texas
$649 +$649 +79 New
CG
2
Carmignac Gestion
France
-$3.26M -220,882 Closed
VAM
3
Vazirani Asset Management
New York
-$1.62M -109,620 Closed
Barclays
4
Barclays
United Kingdom
-$1.13M -76,450 Closed
GLAM
5
Gardner Lewis Asset Management
Pennsylvania
-$217K -14,698 Closed
Simplex Trading
6
Simplex Trading
Illinois
-$172K -11,722 Closed
Amundi
7
Amundi
France
-$148K -10,058 Closed
SAM
8
Shell Asset Management
Netherlands
-$91K -6,150 Closed
Canada Life
9
Canada Life
Manitoba, Canada
-$54K -3,646 Closed
CUAMC
10
China Universal Asset Management Company
China
-$24.1K -1,634 Closed
LC
11
Lindbrook Capital
California
-$2.3K -156 Closed
Credit Agricole
12
Credit Agricole
France
-$59 -4 Closed

BLU Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q3 2023, worth a combined $649 — down 100% from $6.71M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of BLU and 1 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Coppell Advisory Solutions, opening a new position worth an estimated $649. The largest seller was Carmignac Gestion, exiting entirely with an estimated $3.26M sold.

  • 1 institutional investor held BELLUS Health Inc. (BLU) as of Q3 2023, down from 11 in Q2 2023.
  • Funds reported $649 of BELLUS Health Inc. stock for Q3 2023, down 100% quarter-over-quarter.
  • 1 fund opened new BELLUS Health Inc. positions in Q3 2023 and 11 closed out, a net change of -10 holders.
  • The largest BELLUS Health Inc. buyer in Q3 2023 was Coppell Advisory Solutions, an estimated $649 added.
  • The largest BELLUS Health Inc. seller in Q3 2023 was Carmignac Gestion, an estimated $3.26M sold.

Based on aggregated 13F filings for Q3 2023.